Dolo 650's 1000 crore gifts to doctors!!!

I was also prescribed Dolo-650 pills when I got infected with Corona. It's strange. It's a serious problem."

Referring to Dolo-650 tablet during a trial, supreme court Justice TY Chandrachud said this. With this case, the Tolo-650 is back in the media headlines.

For prescribing Dolo-650 tablets, doctors are charged around Rs. According to media reports, Ammathirai's production company has given away free gifts worth Rs 1,000 crore.

This information is based on a press release issued by the Income Tax Department. Details of this report of the Income Tax Department were also cited during the trial.

The pill came into limelight due to its record-breaking sales during the Corona pandemic. 

What is the case?

A case was filed in the supreme court on behalf of the Confederation of indian Medical and Sales Representatives Association. But this case is not about Dolo-650 tablet.

A petition filed by the Federation of indian Medical and Sales Representative Associations has sought to lay down uniform legal norms for drug marketing practices. It has been requested in the petition that if the government does not bring a law in this regard, the supreme court should intervene and issue an order to the government of india in this regard.

It was argued by the petitioner that pharmaceutical companies spend a lot on marketing their drugs, thereby forcing doctors to prescribe these drugs to patients.

Petitioner's lawyer Sanjay Parikh said, "Companies give many free gifts to doctors for prescribing their medicines. But no action is taken against these companies. Giving free gifts to doctors is like bribing them. So, action should be taken against both the parties. That is why prices of medicines, "We are insisting on framing of common norms for regularization of marketing. We have been insisting on this demand since 2008-2009," he said.

What are the marketing regulations for drugs?

Pharmaceutical companies can formulate Voluntary Code of Practice for Marketing of Medicines in India.

On december 12, 2014, the government of india directed the pharmaceutical companies to frame their own rules for the next 6 months, and then the government of india asked them to review these rules and give them legal form.

The petitioner's lawyer has said that the government of india has prepared a draft to legalize this, and said that recommendations have been received but they have not been enacted.

In response to a question asked in this regard in the lok sabha this month, the government of india said that it would continue to frame the rules itself.

Government of india should frame some new binding law in this regard. But no recommendation or proposal for the same has reached the government from any civil society or patent group.

The government of india in its reply also stated that there are two more laws relating to the marketing of medicines. As the case in this regard is pending in the court, there is no need to make a binding law.

The supreme court has ordered the government of india to respond in this case within 10 days.